15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 2 firms covering Emera Incorporated, 0 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a hold consensus. Targets are tightly clustered, $52.00 to $68.00, so the covering firms are broadly aligned. The average target of $60.00 sits 10% above the current $54.48. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.69 next quarter toward $2.60 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS2 ratings
Hold
Strong Buy00%
Buy00%
Hold2100%
Sell00%
Strong Sell00%
Based on 2 analysts giving stock ratings to Emera Incorporated.
As of Jul, 0 of 2 firms rate EMA a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
EMA EPS & revenue forecast
EPS · NEXT QUARTER
$0.69
Range $0.65 – $0.72 · 9 analysts · +11% YoY
Next period, 9 analysts expect Emera Incorporated to earn $0.69 a share (range $0.65 – $0.72), versus $0.63 a year earlier. Full-year consensus is $2.67, growing to $2.60 the year after.
REVENUE · NEXT QUARTER
$2.3B
Range $2.3B – $2.3B · 9 analysts · +9% YoY
Revenue is expected to reach $2.3B (range $2.3B – $2.3B), +8.9% year-over-year. Full-year consensus is $9.2B, rising to $9.2B next year.
Top analysts covering Emera Incorporated
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on EMA.
#1
ML
Michael Lonegan
Barclays
Hold
$52.00-4.6% to target
Coverage
—
+ Follow
#2
EJ
Eli Jossen
JP Morgan
Hold
$73.00+34.0% to target
Coverage
—
+ Follow
#3
Ross Fowler
B of A Securities
Hold
$74.00+35.8% to target
Coverage
—
+ Follow
#4
BS
Brent Stadler
Desjardins
Hold
$69.00+26.7% to target
Coverage
—
+ Follow
#5
Joseph Parkhill
UBS
Hold
$72.00+32.2% to target
Coverage
—
+ Follow
EMA stock forecast FAQ
What is EMA's average 12-month price target?+
The 2 analysts with a live target average $60.00 for Emera Incorporated over the next 12 months, ranging from a $68.00 high to a $52.00 low.
Is EMA stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 2 analyst ratings, 0 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for EMA?+
The Street-high target is $68.00 (CIBC), and the Street-low is $52.00 (Barclays). The average of all 2 active targets is $60.00.
How many Wall Street analysts cover EMA?+
2 analysts have an active rating on Emera Incorporated, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering EMA?+
Among analysts who currently cover EMA, Michael Lonegan of Barclays has the strongest overall Quantellect track record. Their current call is Hold with a $52.00 target.
What is Emera Incorporated's projected EPS for next quarter?+
The consensus estimate is $0.69 per share (range $0.65 – $0.72) across 9 analysts. Full-year EPS is projected at $2.67, rising to $2.60 the following year.
How much revenue is Emera Incorporated expected to report next quarter?+
Consensus revenue is $2.3B (range $2.3B – $2.3B). Full-year revenue is projected at $9.2B, growing to $9.2B next year.
Have analysts been upgrading or downgrading EMA lately?+
As of Jul, 0 of 2 firms rate EMA a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their EMA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
